STADA Arzneimittel AG

Alvotech's Swedish Depository Receipts (SDRs) offering was multiple times oversubscribed, attracting over 3,000 new shareholders and raising approximately SEK 39 million.

Bio-Thera Solutions achieves milestone as the European Medicines Agency accepts marketing application for BAT2506, marking the first golimumab biosimilar from a Chinese company submitted for EU approval.

The European Medicines Agency (EMA) has accepted Alvotech's Marketing Authorization Application for AVT03, a biosimilar candidate to Prolia and Xgeva.